Industry
Avida Labs to produce new cosmetic range by Dermactiva
Three new products, launching in summer 2022, will contain Avida Global’s own high-quality CBD oil.
Avida Labs will manufacture the new skin and body care range from cannabis-based, Colombian cosmetic brand, Dermactiva.
Healthcare Branding Ltd has appointed Avida Labs, Europe’s leading CBD manufacturing business, to produce its new soon-to-be-launched skin and body care range under the Dermactiva Brand.
Using Dermactiva’s heritage formulations drawing on 25 years of Colombian expertise, Avida Labs will formulate and manufacture Dermactiva’s three new products using its own high-quality CBD oil, cultivated and produced at its GMP compliant, ISO certified facility in North-East Colombia. The new range is set to launch in Summer 2022.
Avida Labs is the manufacturing arm of Avida Global.
Avida Labs offers companies, from early-stage entrepreneurs to major brands looking to get a foothold in the CBD industry, access to a suite of services including in-house formulation and testing, research & development, bottling, packaging and design. Customers can choose from a broad variety of CBD oils including Avida Global’s own.
The new range from Dermactiva
Nathan Whitman, managing director of Avida Labs, commented: “We are proud to partner with Dermactiva for this exciting new launch. We share many synergies not least our shared Colombian heritage and our ethos of prioritising purity and traceability across our entire ecosystem.”
Claudia Avila-Batchelor, Dermactiva’s Colombian co-founder, emphasised her brand’s unique position, adding: “Colombia’s terrain and climate produce arguably the best natural cannabis in the world. We are thrilled to be able to offer our unique formulations with the premium Colombian oil that Avida Global are exclusively blending for us. This will be a game-changer in the industry and for consumers.”
-
News4 months agoLuxembourg to Restrict Access to Medical Cannabis Flower on Prescription
-
News4 months agoNHS Accused Of “Failing Patients” As Families Make Fresh Plea For Access
-
Epilepsy5 months agoUCL Launches 2 Medical Cannabis Trials Into Childhood Epilepsy, but Experts Warn It Is Not the Solution Many Have Been Waiting For
-
News6 months agoSpain’s proposed medical cannabis framework too ‘restrictive’, say patients
-
Health2 months agoUK IBD Patients Report Improvements With Medical Cannabis
-
Industry6 months agoUK cannabis clinics Leva and Zerenia merge to expand patient care
-
Science6 months agoStudy finds no link between long-term medical cannabis use and changes in brain function
-
News3 months agoGPs in Czech Republic Permitted To Prescribe Medical Cannabis From 2025
